Aske Thorn Iversen

Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study

Adam S. Faye, Kristine H. Allin, Aske Thorn Iversen et al. · Gut · 2023 · 138 citations · Full text

Public Health, Health Sciences, Population Health Sciences +11

Reducing BMI below the obesity threshold in adolescents treated with once‐weekly subcutaneous semaglutide 2.4 mg

Aaron S. Kelly, Silva Arslanian, Dan Hesse et al. · Obesity · 2023 · 49 citations · Full text

Agriculture, Endocrinology, Pharmacotherapy +17

Increasing Incidence of Pouchitis Between 1996 and 2018: A Population-Based Danish Cohort Study

Edward L. Barnes, Kristine H. Allin, Aske Thorn Iversen et al. · Clinical Gastroenterology and Hepatology · 2022 · 44 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +9

Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases

Siddharth Singh, Aske Thorn Iversen, Kristine H. Allin et al. · JAMA Network Open · 2022 · 33 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +14

Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases

Daniel Ward, Nynne Nyboe Andersen, Sanne Gørtz et al. · Clinical Gastroenterology and Hepatology · 2023 · 24 citations · Full text

Life Sciences, Immunology, Pharmacology +16